Intravitreal VEGF blockade agents vs PRP for cases of PDR

Retinal Debate about the utilization of intravitreal VEGF blockade agents vs PRP for cases of PDR

In this webinar Mayssam Haykalliya will debate the use of intravitreal VEGF blockade agents for PDR vs Dr. Zeina Al junaidi, MD, FICO, ABO, SBO which will debate the use of PRP for PDR. As Ameen Marashi, MD, SBO will give the final verdict of rational utilization of the commercially available VEGF blockade agents and PRP. Dr. Ameen will host Dr Noura Almansoori, which is an Emirati consultant ophthalmologist specializing in medical retina and vitreoretinal surgeries. As she will share her experience with VEGF blockade agents and PRP utilization for PDR.

Each talk in this presentation is about five to seven minutes only 

Retinal Debate about observation vs treatment for acute CSCR

In this webinar Joslin Dakhil will debate the use of observation for acute CSCR vs Marah Hadid which will debate the treatment for acute CSCR. As Ameen Marashi, MD, SBO will give the final verdict of rational observtion vs treatment for acute CSCR. Dr. Ameen will host Dr Fahd Quhill, who is a Consultant Ophthalmologist specialising in Medical Retina and Ocular inflammatory disease at Moorfields Eye Hospital Dubai in Dubai Healthcare City. As he will share his experience with approaching acute CSCR.

Each talk in this presentation is about five to seven minutes only using the google meet platform Observation VS treatment for Acute CSCR.

Intravitreal antibiotics vs Vitrectomy for endophthalmitis

In the era of vitrectomy, is there still a role for antibiotics ?

But, if we lack facilities and experts, are antibiotics sufficient to treat this devastating disease?

All of this and more will be discussed in our debate - mark your calendars and come!